Literature DB >> 16186228

IgA-coated particles of Hepatitis A virus are translocalized antivectorially from the apical to the basolateral site of polarized epithelial cells via the polymeric immunoglobulin receptor.

Andreas Dotzauer1, Meike Brenner1, Ulrike Gebhardt1, Angelika Vallbracht1.   

Abstract

Although Hepatitis A virus (HAV) is transmitted by the faecal-oral route, its target for replication is the liver. Little is known of its interactions with cells of the gastrointestinal tract, and it is not known by which mechanisms HAV crosses the intestinal epithelium. In this study, it is shown that HAV associated with IgA is translocated from the apical to the basolateral compartment of polarized epithelial cells via the polymeric immunoglobulin receptor by IgA-mediated reverse transcytosis. The relevance of this mechanism, by which HAV-IgA complexes may overcome the intestinal barrier and contribute to infections of the liver, results from the fact that HAV-IgA complexes are infectious for hepatocytes and that significant amounts of intestinal HAV-IgA are present during acute infections, which are also partly transmitted. Besides supporting the primary infection, this mechanism may play a role in relapsing infections by establishing an enterohepatic cycle for HAV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186228     DOI: 10.1099/vir.0.81157-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions.

Authors:  Cecilia Tami; Erica Silberstein; Mohanraj Manangeeswaran; Gordon J Freeman; Sarah E Umetsu; Rosemarie H DeKruyff; Dale T Umetsu; Gerardo G Kaplan
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  Vectorial entry and release of hepatitis A virus in polarized human hepatocytes.

Authors:  Michelle J Snooks; Purnima Bhat; Jason Mackenzie; Natalie A Counihan; Nicola Vaughan; David A Anderson
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

Review 3.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

Review 4.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

5.  Identification of a novel cellular target and a co-factor for norovirus infection - B cells & commensal bacteria.

Authors:  Stephanie M Karst
Journal:  Gut Microbes       Date:  2015-05-21

Review 6.  Hepatitis A Virus Capsid Structure.

Authors:  David I Stuart; Jingshan Ren; Xiangxi Wang; Zihe Rao; Elizabeth E Fry
Journal:  Cold Spring Harb Perspect Med       Date:  2019-05-01       Impact factor: 6.915

Review 7.  The cell biology of receptor-mediated virus entry.

Authors:  Joe Grove; Mark Marsh
Journal:  J Cell Biol       Date:  2011-11-28       Impact factor: 10.539

8.  Hepatitis A virus and the origins of picornaviruses.

Authors:  Xiangxi Wang; Jingshan Ren; Qiang Gao; Zhongyu Hu; Yao Sun; Xuemei Li; David J Rowlands; Weidong Yin; Junzhi Wang; David I Stuart; Zihe Rao; Elizabeth E Fry
Journal:  Nature       Date:  2014-10-19       Impact factor: 49.962

9.  Specific IgA Enhances the Transcytosis and Excretion of Hepatitis A Virus.

Authors:  Natalie A Counihan; David A Anderson
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

10.  TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.

Authors:  Anshuman Das; Asuka Hirai-Yuki; Olga González-López; Bethany Rhein; Sven Moller-Tank; Rachel Brouillette; Lucinda Hensley; Ichiro Misumi; William Lovell; John M Cullen; Jason K Whitmire; Wendy Maury; Stanley M Lemon
Journal:  mBio       Date:  2017-09-05       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.